Investigational Drug Information for Cytisinicline
✉ Email this page to a colleague
What is the drug development status for Cytisinicline?
Cytisinicline is an investigational drug.
There have been 7 clinical trials for Cytisinicline.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2022.
The most common disease conditions in clinical trials are Renal Insufficiency and [disabled in preview]. The leading clinical trial sponsors are Achieve Life Sciences and [disabled in preview].
There are two hundred and sixty-three US patents protecting this investigational drug and zero international patents.
Summary for Cytisinicline
| US Patents | 263 |
| International Patents | 1,942 |
| US Patent Applications | 753 |
| WIPO Patent Applications | 431 |
| Japanese Patent Applications | 84 |
| Clinical Trial Progress | Phase 1 (2022-01-01) |
| Vendors | 54 |
Recent Clinical Trials for Cytisinicline
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate Effect of Food on Bioavailability of Single 3 mg Tablet and Pharmacokinetics (PK) of Multiple 3 mg Doses in Healthy Adult Smokers | Achieve Life Sciences | Phase 1 |
| Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose | Achieve Life Sciences | Phase 1 |
| Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers | Achieve Life Sciences | Phase 1 |
Clinical Trial Summary for Cytisinicline
Top disease conditions for Cytisinicline
Top clinical trial sponsors for Cytisinicline
US Patents for Cytisinicline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Cytisinicline | ⤷ Sign Up | Methods and compositions for treating infection | UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS) | ⤷ Sign Up |
| Cytisinicline | ⤷ Sign Up | Use of neural cells derived from human pluripotent stem cells for the treatment of neurodegenerative diseases | International Stem Cell Corporation (Carlsbad, CA) | ⤷ Sign Up |
| Cytisinicline | ⤷ Sign Up | Nicotinic attenuation of CNS inflammation and autoimmunity | Dignity Health (San Francisco, CA) | ⤷ Sign Up |
| Cytisinicline | ⤷ Sign Up | Dietary supplements and formulations | Eastern Vision Limited (Wanchai, HK) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Cytisinicline
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Cytisinicline | World Intellectual Property Organization (WIPO) | WO2014052836 | 2032-09-27 | ⤷ Sign Up |
| Cytisinicline | European Patent Office | EP2961277 | 2033-02-15 | ⤷ Sign Up |
| Cytisinicline | Hong Kong | HK1215358 | 2033-02-15 | ⤷ Sign Up |
| Cytisinicline | Japan | JP2016508520 | 2033-02-15 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
